1. Juarez-Mendez S, Zentella-Dehesa A, Villegas-Ruiz V, Perez-Gonzalez OA, Salcedo M, Lopez-Romero R, Roman-Basaure E, Lazos-Ochoa M, Montes de Oca-Fuentes VE, Vazquez-Ortiz G et al: Splice variants of zinc finger protein 695 mRNA associated to ovarian cancer. J Ovarian Res 2013, 6(1):61.
2. Treatment of recurrent epithelial ovarian cancer;Pignata S;Cancer,2019
3. Treatment of recurrent ovarian cancer;Pignata S;Ann Oncol,2017
4. Bookman MA, Okamoto A, Stuart G, Yanaihara N, Aoki D, Bacon M, Fujiwara K, Gonzalez-Martin A, Harter P, Kim JW et al: Harmonising clinical trials within the Gynecologic Cancer InterGroup: consensus and unmet needs from the Fifth Ovarian Cancer Consensus Conference. Ann Oncol 2017, 28(suppl_8):viii30-viii35.
5. Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: The AURELIA open-label randomized phase III trial;Pujade-Lauraine E;J Clin Oncol,2014